Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114070152 | 11407015 | 2 | F | 201505 | 20160113 | 20150821 | 20160826 | PER | US-NOVOPROD-453528 | NOVO NORDISK | 58.00 | YR | A | F | Y | 86.62000 | KG | 20160826 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114070152 | 11407015 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.8 MG, QD | Y | UNKNOWN | 22341 | 1.8 | MG | SOLUTION FOR INJECTION | QD | ||||
| 114070152 | 11407015 | 2 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 65 UNITS TWICE DAILY | 0 | 65 | DF | SOLUTION FOR INJECTION | BID | ||||||
| 114070152 | 11407015 | 3 | C | HUMALOG | INSULIN LISPRO | 1 | 0 | ||||||||||||
| 114070152 | 11407015 | 4 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 114070152 | 11407015 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 114070152 | 11407015 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 60 MG, QD | 0 | 60 | MG | QD | ||||||||
| 114070152 | 11407015 | 7 | C | HYDROCHLOROTH | HYDROCHLOROTHIAZIDE | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 114070152 | 11407015 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0.1 MG, QD | 0 | .1 | MG | QD | ||||||||
| 114070152 | 11407015 | 9 | C | LOSARTAN. | LOSARTAN | 1 | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 114070152 | 11407015 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114070152 | 11407015 | 1 | Type 2 diabetes mellitus |
| 114070152 | 11407015 | 2 | Type 2 diabetes mellitus |
| 114070152 | 11407015 | 3 | Type 2 diabetes mellitus |
| 114070152 | 11407015 | 4 | Product used for unknown indication |
| 114070152 | 11407015 | 5 | Product used for unknown indication |
| 114070152 | 11407015 | 6 | Product used for unknown indication |
| 114070152 | 11407015 | 7 | Product used for unknown indication |
| 114070152 | 11407015 | 8 | Product used for unknown indication |
| 114070152 | 11407015 | 9 | Product used for unknown indication |
| 114070152 | 11407015 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114070152 | 11407015 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114070152 | 11407015 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114070152 | 11407015 | 1 | 201505 | 0 |